Bosulif 400 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM0NU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,452
Award facts
- Contract value 100% obligated
- $12,451.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bosulif 400 mg tablets (30-count units) on December 15, 2025, with a ceiling value of $12,451.85 and an ultimate completion date of January 7, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. Bosulif is a specialized oncology medication, consistent with the company's portfolio of brand-name and generic pharmaceuticals across multiple therapeutic domains. Through its substantial prime IDC with the DLA, AmerisourceBergen serves as a primary pharmaceutical supplier to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis, enabling flexible fulfillment of medical supply needs across the federal healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26FM0NU?
SPE2DR26FM0NU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26FM0NU worth?
The government has obligated $12,452 on SPE2DR26FM0NU.
Is contract SPE2DR26FM0NU an order under another contract?
Yes. SPE2DR26FM0NU is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM0NU competed?
The extent of competition for SPE2DR26FM0NU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award